Daye’s Diagnostic Tampon is an innovative at-home screening technology for detecting sexually transmitted infections (STIs) and human papillomavirus (HPV). 

This tampon-based test allows women and assigned female at birth (AFAB) individuals to collect samples comfortably and non-invasively in their own homes. 

The technology addresses several key problems in gynecological health screening. It eliminates the need for clinic visits, making testing more accessible and convenient. The familiar tampon format reduces discomfort and anxiety associated with traditional screening methods. 

Moreover, the tampon collects a larger, more comprehensive sample compared to swabs, improving test accuracy. By encouraging more frequent testing, it enables earlier detection of STIs and HPV. 

Additionally, at-home testing provides a discreet option for those who may feel embarrassed about clinic visits. By addressing these issues, Daye’s technology aims to increase screening rates, improve early detection, and ultimately contribute to better gynecological health outcomes.

Daye’s competitive edge lies in our unique in-house manufacturing capabilities, which set us apart in the medical device industry. This vertical integration allows us to rapidly implement patient feedback into our product design, ensuring our diagnostic tampons continuously evolve to meet user needs. Our agile approach enables us to swiftly iterate and improve our technology, staying ahead of market demands. Furthermore, our in-house production grants us greater control over quality, costs, and supply chain, enhancing our ability to deliver innovative, user-centric solutions. This combination of patient-driven design and manufacturing agility is Daye’s superpower, allowing us unparalleled responsiveness and efficiency.